International Journal of Infectious Diseases (Jan 2022)
Surging bloodstream infections and antimicrobial resistance during the first wave of COVID–19: a study in a large multihospital institution in the Paris region
- Rishma Amarsy,
- David Trystram,
- Emmanuelle Cambau,
- Catherine Monteil,
- Sandra Fournier,
- Juliette Oliary,
- Helga Junot,
- Pierre Sabatier,
- Raphaël Porcher,
- Jérôme Robert,
- Vincent Jarlier,
- Guillaume Arlet,
- Laurence Armand Lefevre,
- Alexandra Aubry,
- Laurent Belec,
- Béatrice Bercot,
- Stéphane Bonacorsi,
- Vincent Calvez,
- Emmanuelle Cambau,
- Etienne Carbonnelle,
- Stéphane Chevaliez,
- Jean-Winoc Decousser,
- Constance Delaugerre,
- Diane Descamps,
- Florence Doucet-Populaire,
- Jean-Louis Gaillard,
- Antoine Garbarg- Chenon,
- Elyanne Gault,
- Jean-Louis Herrmann,
- Vincent Jarlier,
- Jérôme Le Goff,
- Jean-Christophe Lucet,
- Jean-Luc Mainardi,
- Anne-Geneviève Marcellin,
- Laurence Morand-Joubert,
- Xavier Nassif,
- Jean-Michel Pawlotsky,
- Jérôme Robert,
- Anne-Marie Roque Afonso,
- Martin Rottman,
- Christine Rouzioux,
- Flore Rozenberg,
- François Simon,
- Nicolas Veziris,
- David Skurnik,
- Jean-Ralph Zahar,
- Guilene Barnaud,
- Typhaine Billard Pomares,
- Gaëlle Cuzon,
- Dominique Decré,
- Alexandra Doloy,
- Jean-Luc Donay,
- Laurence Drieux-Rouzet,
- Isabelle Durand,
- Agnès Ferroni,
- Vincent Fihman,
- Nicolas Fortineau,
- Camille Gomart,
- Nathalie Grall,
- Christelle Guillet Caruba,
- Françoise Jaureguy,
- Valérie Lalande,
- Luce Landraud,
- Véronique Leflon,
- Patricia Mariani,
- Liliana Mihaila,
- Didier Moissenet,
- Latifa Noussair,
- Isabelle Podglajen,
- Isabelle Poilane,
- Hélène Poupet,
- Emilie Rondinaud,
- Valérie Sivadon Tardy,
- David Trystram,
- Charlotte Verdet,
- Emmanuelle Vigier,
- Sophie Vimont Billarant
Affiliations
- Rishma Amarsy
- Groupe hospitalo-universitaire APHP Nord-Université de Paris, Site Lariboisière et Fernand Widal, Infection Prevention and Control Team and CIMI-Paris, Inserm U1135, Sorbonne Université, Paris, France
- David Trystram
- Groupe hospitalo-universitaire APHP Sorbonne Université, Site Pitié-Salpêtrière, Laboratoire de Bactériologie-Hygiène, Paris, France and Direction des Systèmes d'Information de l'Assistance Publique – Hôpitaux de Paris, Paris, France
- Emmanuelle Cambau
- Groupe hospitalo-universitaire APHP Nord -Université de Paris, Site Lariboisière, Laboratoire de Microbiologie-Hygiène and Inserm UMR1137 IAME, Paris, France
- Catherine Monteil
- Central Infection Control Team, Assistance Publique – Hôpitaux de Paris, Paris, France
- Sandra Fournier
- Central Infection Control Team, Assistance Publique – Hôpitaux de Paris, Paris, France
- Juliette Oliary
- Groupe hospitalo-universitaire APHP Nord-Université de Paris, Site Lariboisière, Pharmacie, Paris, France
- Helga Junot
- Groupe hospitalo-universitaire APHP Sorbonne Université, Site Pitié-Salpêtrière, Pharmacie, Paris, France
- Pierre Sabatier
- Agence Générale des Equipements et Produits de Santé, Assistance Publique – Hôpitaux de Paris, Pharmacie, Paris, France
- Raphaël Porcher
- Groupe hospitalo-universitaire APHP Centre-Université de Paris, Site Hôtel-Dieu, Centre for Clinical Epidemiology, Paris, France; Université de Paris, CRESS UMR1153, INSERM, INRAE, Paris, France
- Jérôme Robert
- Groupe hospitalo-universitaire APHP Sorbonne Université, Site Pitié-Salpêtrière, Laboratoire de Bactériologie-Hygiène and CIMI-Paris, Inserm U1135, Sorbonne Université, Paris, France
- Vincent Jarlier
- Groupe hospitalo-universitaire APHP Sorbonne Université, Site Pitié-Salpêtrière, Laboratoire de Bactériologie-Hygiène and CIMI-Paris, Inserm U1135, Sorbonne Université, Paris, France; Corresponding author: Vincent Jarlier, Equipe “Emergence et diffusion de la multirésistance aux antibiotiques”, Centre d'Immunologie et des Maladies Infectieuses (CIMI), 91 boulevard de l'Hôpital, 75013 Paris, France. Tel: +33 1 40 77 95 56.
- Guillaume Arlet
- Laurence Armand Lefevre
- Alexandra Aubry
- Laurent Belec
- Béatrice Bercot
- Stéphane Bonacorsi
- Vincent Calvez
- Emmanuelle Cambau
- Etienne Carbonnelle
- Stéphane Chevaliez
- Jean-Winoc Decousser
- Constance Delaugerre
- Diane Descamps
- Florence Doucet-Populaire
- Jean-Louis Gaillard
- Antoine Garbarg- Chenon
- Elyanne Gault
- Jean-Louis Herrmann
- Vincent Jarlier
- Jérôme Le Goff
- Jean-Christophe Lucet
- Jean-Luc Mainardi
- Anne-Geneviève Marcellin
- Laurence Morand-Joubert
- Xavier Nassif
- Jean-Michel Pawlotsky
- Jérôme Robert
- Anne-Marie Roque Afonso
- Martin Rottman
- Christine Rouzioux
- Flore Rozenberg
- François Simon
- Nicolas Veziris
- David Skurnik
- Jean-Ralph Zahar
- Guilene Barnaud
- Typhaine Billard Pomares
- Gaëlle Cuzon
- Dominique Decré
- Alexandra Doloy
- Jean-Luc Donay
- Laurence Drieux-Rouzet
- Isabelle Durand
- Agnès Ferroni
- Vincent Fihman
- Nicolas Fortineau
- Camille Gomart
- Nathalie Grall
- Christelle Guillet Caruba
- Françoise Jaureguy
- Valérie Lalande
- Luce Landraud
- Véronique Leflon
- Patricia Mariani
- Liliana Mihaila
- Didier Moissenet
- Latifa Noussair
- Isabelle Podglajen
- Isabelle Poilane
- Hélène Poupet
- Emilie Rondinaud
- Valérie Sivadon Tardy
- David Trystram
- Charlotte Verdet
- Emmanuelle Vigier
- Sophie Vimont Billarant
- Journal volume & issue
-
Vol. 114
pp. 90 – 96
Abstract
Objectives: This study measured the impact of the first wave of COVID-19 pandemic (COVID-19) (March–April 2020) on the incidence of bloodstream infections (BSIs) at Assistance Publique – Hôpitaux de Paris (APHP), the largest multisite public healthcare institution in France. Methods: The number of patient admission blood cultures (BCs) collected, number of positive BCs, and antibiotic resistance and consumption were analysed retrospectively for the first quarter of 2020, and also for the first quarter of 2019 for comparison, in 25 APHP hospitals (ca. 14 000 beds). Results: Up to a fourth of patients admitted in March–April 2020 in these hospitals had COVID-19. The BSI rate per 100 admissions increased overall by 24% in March 2020 and 115% in April 2020, and separately for the major pathogens (Escherichia coli, Klebsiella pneumoniae, enterococci, Staphylococcus aureus, Pseudomonas aeruginosa, yeasts). A sharp increase in the rate of BSIs caused by microorganisms resistant to third-generation cephalosporins (3GC) was also observed in March–April 2020, particularly in K. pneumoniae, enterobacterial species naturally producing inducible AmpC (Enterobacter cloacae...), and P. aeruginosa. A concomitant increase in 3GC consumption occurred. Conclusions: The COVID-19 pandemic had a strong impact on hospital management and also unfavourable effects on severe infections, antimicrobial resistance, and laboratory work diagnostics.